Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
1994-1-6
|
pubmed:abstractText |
The aim of this study was to determine the minimum prevalence of coeliac disease in a group of 459 diabetic children and adolescents. Six patients were already known to have coeliac disease. A total of 436 patients with type 1 diabetes mellitus aged 2-21 years and with age at onset at 2 months to 17 years at three paediatric departments agreed to participate in the study. All patients were tested for gliadin IgA antibodies with a commercial kit (Pharmacia Gluten IgA EIA). Later, serum was tested for reticulin IgA/IgG antibodies. Nineteen patients had elevated gliadin IgA levels (> 25 AU). Eighteen underwent jejunal biopsy. Ten had total or subtotal villous atrophy. These 10 patients were reticulin IgA-positive. Of 417 gliadin IgA-negative patients, 408 were reticulin IgA/IgG-negative. Of 6 reticulin IgA-positive patients, 3 had total or subtotal villous atrophy. All 3 had become gliadin IgA-positive at the time of biopsy. Among 3 reticulin IgG-positive patients with IgA deficiency, 2 had total villous atrophy: 1 was not willing to be biopsied. Patients with total or subtotal villous atrophy were judged as having coeliac disease and were recommended a gluten-free diet. Within 2 months, gliadin IgA levels were normal in patients adhering to the diet. Five patients have gone through a second jejunal biopsy to date with normal histology in all 5. The 15 newly diagnosed patients with coeliac disease plus 6 already known patients with coeliac disease and type 1 diabetes mellitus gave a minimum prevalence of coeliac disease in diabetic children and adolescents of 21/459 = 4.6%.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0803-5253
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
82
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
748-51
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8241671-Adolescent,
pubmed-meshheading:8241671-Adult,
pubmed-meshheading:8241671-Atrophy,
pubmed-meshheading:8241671-Celiac Disease,
pubmed-meshheading:8241671-Child,
pubmed-meshheading:8241671-Child, Preschool,
pubmed-meshheading:8241671-Diabetes Mellitus, Type 1,
pubmed-meshheading:8241671-Female,
pubmed-meshheading:8241671-Humans,
pubmed-meshheading:8241671-Immunoglobulin A,
pubmed-meshheading:8241671-Immunoglobulin G,
pubmed-meshheading:8241671-Jejunum,
pubmed-meshheading:8241671-Male,
pubmed-meshheading:8241671-Prevalence,
pubmed-meshheading:8241671-Sweden
|
pubmed:year |
1993
|
pubmed:articleTitle |
Prevalence of coeliac disease in diabetic children and adolescents in Sweden.
|
pubmed:affiliation |
Department of Pediatrics, Bordås Hospital, Sweden.
|
pubmed:publicationType |
Journal Article
|